Sanofi boosts its mRNA capabilities with Translate Bio acquisition

3rd August 2021 Uncategorised 0

Sanofi will acquire Translate Bio for approximately $3.2bn, or $38.00 per share in cash

More: Sanofi boosts its mRNA capabilities with Translate Bio acquisition
Source: News